{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:07:29Z","timestamp":1789805249019,"version":"4.0.1"},"reference-count":29,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2026,9]]},"abstract":"\n Objective<\/jats:title>\n Moxifloxacin, a widely used fluoroquinolone, has been associated with oxidative stress and tissue injury. Resveratrol may attenuate oxidative damage. This study investigated the effects of resveratrol co-administration on oxidative and apoptotic biomarkers in rats exposed to moxifloxacin.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Twenty-four male Wistar albino rats were randomly assigned to three groups (n\u2009=\u20098 per group): (a) control; (b) moxifloxacin; and (c) moxifloxacin + resveratrol groups. Moxifloxacin was administered intraperitoneally at 50\u2005mg\/kg\/day during the final 7 days of a 28-day experimental period, whereas resveratrol was administered at 40\u2005mg\/kg\/day for 28 days. Levels of superoxide dismutase, malondialdehyde, and caspase-3 as well as total antioxidant status and total oxidant status were assessed in the serum, brain, kidney, and liver tissues.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Serum total antioxidant status significantly decreased in the moxifloxacin group compared with that in the control group (2.639\u2009\u00b1\u20090.169 vs. 3.531\u2009\u00b1\u20090.176\u2005mmol Trolox equivalent\/L,\n p<\/jats:italic>\n \u2009=\u20090.007). Co-administration of moxifloxacin and resveratrol significantly increased serum total antioxidant status compared with administration of moxifloxacin alone (3.380\u2009\u00b1\u20090.190 vs. 2.639\u2009\u00b1\u20090.169\u2005mmol Trolox equivalent\/L,\n p<\/jats:italic>\n \u2009=\u20090.018), whereas no significant difference was observed in the control group (\n p<\/jats:italic>\n \u2009=\u20090.557). Kidney total oxidant status was significantly higher in the moxifloxacin group than in the control (\n p<\/jats:italic>\n \u2009=\u20090.008) and moxifloxacin + resveratrol (\n p<\/jats:italic>\n \u2009=\u20090.002) groups. Liver superoxide dismutase levels were significantly lower in the moxifloxacin group than in the control (\n p<\/jats:italic>\n \u2009<\u20090.001) and moxifloxacin + resveratrol (\n p<\/jats:italic>\n \u2009=\u20090.001) groups. Kidney caspase-3 levels were significantly increased in the moxifloxacin group compared with those in the control group (\n p<\/jats:italic>\n \u2009<\u20090.001), whereas co-administration of moxifloxacin and resveratrol partially attenuated this alteration. Additionally, moxifloxacin increased the levels of malondialdehyde in the kidney, liver, and brain tissues, with attenuation following resveratrol co-administration.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Resveratrol co-administration attenuated several moxifloxacin-associated oxidative and apoptotic alterations, particularly in the kidney and liver tissues. However, the absence of a resveratrol-only group and the preconditioning design limit the interpretation of its independent effects and clinical applicability. Further pharmacokinetic, mechanistic, and clinical studies are required.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/03000605261488102","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:25:20Z","timestamp":1789543520000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Resveratrol attenuates moxifloxacin-induced oxidative damage in the liver, kidneys, brain, and serum of Wistar rats"],"prefix":"10.1177","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5300-6607","authenticated-orcid":false,"given":"G\u00fclfem","family":"Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[{"name":"Private Medicana Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fen","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[{"name":"Uluda\u011f University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106442"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00029.2006"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.4c00128"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200320040-00005"},{"key":"e_1_3_3_6_2","first-page":"39","article-title":"Oxidative stress and apoptosis induced by moxifloxacin in human liver cells","volume":"206","author":"Kushwaha P","year":"2013","unstructured":"Kushwaha P, Saxena G, Lal J, et al. Oxidative stress and apoptosis induced by moxifloxacin in human liver cells. Chem Biol Interact 2013; 206: 39\u201347.","journal-title":"Chem Biol Interact"},{"key":"e_1_3_3_7_2","volume-title":"Guide for the care and use of laboratory animals,","author":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals","unstructured":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals, 8th ed, 2011.","edition":"8"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph3123570"},{"key":"e_1_3_3_9_2","article-title":"Resveratrol antagonizes antimicrobial lethality and stimulates recovery of bacterial mutants","volume":"11","author":"Liu Y","year":"2016","unstructured":"Liu Y, Zhou J, Qu Y, et al. Resveratrol antagonizes antimicrobial lethality and stimulates recovery of bacterial mutants. PLOS One 2016; 11: e0153023.","journal-title":"PLOS One"},{"key":"e_1_3_3_10_2","first-page":"9932218","article-title":"Effects and mechanisms of resveratrol on aging and age-related diseases","author":"Zhou DD","unstructured":"Zhou DD, Luo M, Huang SY, et al. Effects and mechanisms of resveratrol on aging and age-related diseases. Oxid Med Cell Longev 2021; 2021: 9932218.","journal-title":"Oxid Med Cell Longev"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15708"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6030091"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15193"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/192724"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5571733"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2003.10.005"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006055"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","unstructured":"Hong Y Li Q Gao Q et al. Reactive oxygen species play a dominant role in all pathways of rapid quinolone-mediated killing. J Antimicrob Chemother 2020; 75: 576\u2013585.","DOI":"10.1093\/jac\/dkz485"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/10715760902736275"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2021.1982624"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176206"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2060"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02280-5"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26010229"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-011-9395-y"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113000"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2017.11.001"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.01079"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-024-00809-8"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.111823"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261488102","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605261488102","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261488102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:19:58Z","timestamp":1789802398000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605261488102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/03000605261488102"],"URL":"https:\/\/doi.org\/10.1177\/03000605261488102","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"article-number":"03000605261488102"}}